Follow The Filings

DCOY Decoy Therapeutics

Decoy Therapeutics earnings company data as of 4:48 AM ET 10/24

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 13 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by DCOY's executives, directors and 10% owners in the last 12 months, from their Form 4s

All DCOY insider trades
  • $20K bought by 2 insiders
  • $17 sold by 1 insider outside a trading plan
  • None no planned (10b5-1) sales
  1. Arnold C Hanish Director
    Sale
    $17 27 shares at $0.6400
    Traded Dec 30, 2025 Filed Jan 2
    ↗
  2. Arnold C Hanish Director
    Buy
    $3,741 5,000 shares at $0.7500 +33333% to stake
    Traded Nov 20, 2025 Filed Nov 24, 2025
    ↗
  3. Mark J Rosenblum CFO
    Buy
    $16K 20,000 shares at $0.8000 +11299% to stake
    Traded Nov 20, 2025 Filed Nov 20, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 10 stock grants.

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
424B3 Filing Doc
S-1 Filing Doc
8-K 1.01,3.02,7.01,9.01 Filing Doc
8-K 5.07 Filing Doc
SCHEDULE 13G — Filing Doc
10-Q Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
424B3 Filing Doc
8-K 5.07 Filing Doc
S-1 Filing Doc
8-K 1.01,3.02,7.01,9.01 Filing Doc
S-1 Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
8-K 5.08,8.01 Filing Doc
10-Q Filing Doc
10-K/A Filing Doc
8-K 8.01,9.01 Filing Doc
10-K Filing Doc
8-K 3.03,5.03,8.01,9.01 Filing Doc
8-K 5.07 Filing Doc
SCHEDULE 13G/A — Filing Doc
DEF 14A Filing Doc
8-K 5.03,8.01,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 7 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.